Embedding resorcinarene cavitands in lipid vesicles().

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Stability and compatibility of resorcin[4]arene hexamer cages with amphiphilic random copolymers in organic solvents.RSC advances · 2026
   Article
2. Calixarene-mediated liquid membrane transport of choline conjugates 3: The effect of handle variation on neurotransmitter transport.Bioorganic & medicinal chemistry letters · 2017
   Article
3. Calixarene-Mediated Liquid Membrane Transport of Choline Conjugates 2: Transport of Drug-Choline Conjugates and Neurotransmitters.European journal of organic chemistry · 2015
   Article
4. Calixarene-Mediated Liquid-Membrane Transport of Choline Conjugates.European journal of organic chemistry · 2014
   Article
5. Selective cavitand-mediated endocytosis of targeted imaging agents into live cells.Journal of the American Chemical Society · 2013
   Article
6. Materials chemistry: Liposomes derived from molecular vases.Nature · 2012
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

Abstract